BioCryst Pharmaceuticals | 税前利润

Pre Tax Profit 更改 日
DBV Technologies EUR -39258000 22.08M 2022-12
Gilead Sciences USD 2.59B 586M 2023-12
Intra Cellular Therapies USD -28131000 3.92M 2023-12
Ionis Pharmaceuticals USD -3000000 138M 2023-12
Roche Holding CHF 10.33B 1.48B 2023-06
Ultragenyx Pharmaceutical USD -126892000 32.11M 2023-12
Vertex Pharmaceuticals USD 1.31B 9.6M 2023-12



BioCryst Pharmaceuticals 税前利润 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2024.